22NW, LP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001694297
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 16 positions · Total reported value $158.53M · Top-10 concentration 93.1% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 38.9% · 4 new · 0 cut · 3 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.8% · Prev Value $104.68M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.3% · vs SPY -3.4% · Latest Value $144.32M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2024 13F filing, 22NW, LP disclosed 16 equity positions with a combined reported value of $158.53M. The filing implies a focused portfolio: its ten largest positions account for 93.1% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q4 2024 were FSTR ($35.32M), LFCR ($31.15M), ANEB ($25.99M). By sector, the heaviest allocations are Industrials 34.9%, Health Care 22.9%. Versus the prior quarter, allocation shifted toward Materials (+7.7pp) and away from Financials (-1.0pp), Other (-1.4pp).
Versus the prior quarter, 22NW, LP opened 4 new positions, trimmed 0 and fully exited 3, a turnover rate of 38.9% of positions. The portfolio's overlap with the prior quarter was 71% of names.
The largest new positions opened in Q4 2024 were SRI ($2.15M), NKTR ($2.04M), UFI ($1.46M).
Of the 3 positions fully exited versus the prior quarter, the largest were PMD ($637.64K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
Fully Exited (vs previous quarter)
- PMD PSYCHEMEDICS CORP · prev qtr: $637.64K
Insider Transactions (Form 4)
Latest 22NW, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
22NW LP, based in Seattle, WA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 14 positions worth $104.68M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: SEATTLE, WA, United States
- SEC registration: 801-110797 (status: Approved), registered 2017-07-25
- Regulatory AUM (Form ADV): $295.59M as of 2026-03-13
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: englishcap.com
Portfolio Structure
- 14 positions · $104.68M reported value (Q2 2026)
- Top 10 holdings = 94.6% of reported value
- Largest position: NSP (INSPERITY INC) at 19.5%
- Average position size: $7.48M
Sector Tilt
- Consumer Discretionary 59.9%
- Health Care 33.8%
- Industrials 6.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 new, 1 added, 1 reduced, 3 exited
- 11 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.31M | $35.32M | 22.28% | Hold | |
| 2 |
|
1.76M | $31.15M | 19.65% | Hold | |
| 3 |
|
15.47M | $25.99M | 16.39% | Add | |
| 4 |
|
99.78K | $16.81M | 10.60% | Hold | |
| 5 |
|
264.90K | $11.51M | 7.26% | Hold | |
| 6 |
|
1.62M | $9.54M | 6.02% | Add | |
| 7 |
|
117.89K | $5.92M | 3.74% | Hold | |
| 8 |
|
2.60M | $4.61M | 2.91% | Hold | |
| 9 |
|
1.96M | $3.52M | 2.22% | Hold | |
| 10 |
|
356.12K | $3.25M | 2.05% | Hold | |
| 11 |
|
34.56K | $3.09M | 1.95% | Hold | |
| 12 |
|
342.79K | $2.15M | 1.36% | New | |
| 13 |
|
2.19M | $2.04M | 1.29% | New | |
| 14 |
|
537.00K | $1.56M | 0.98% | Hold | |
| 15 |
|
233.78K | $1.46M | 0.92% | New | |
| 16 |
|
276.03K | $618.32K | 0.39% | New | |
FAQ
What did 22NW, LP buy in 2024-Q4?
In its 2024-Q4 13F filing, 22NW, LP reported 16 equity positions worth $158.53M in aggregate; its largest disclosed positions were FSTR ($35.32M), LFCR ($31.15M), ANEB ($25.99M).
How large is 22NW, LP's portfolio?
22NW, LP reported $158.53M of long equity holdings across 16 positions as of 2024-Q4. Top-10 holdings account for 93.1% of reported value.
What is 22NW, LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.